Aberrant redox homoeostasis and mitochondrial dysfunction in Rett syndrome

Area of Science:

• Neuroscience
• Genetics
• Mitochondrial Biology

Background:

• Rett syndrome (RTT) is a severe neurodevelopmental disorder with a single genetic cause but complex symptoms.
• Evidence links RTT to mitochondrial dysfunction and impaired redox homeostasis, leading to oxidative stress.
• Unlike other neuropathologies, RTT shows limited neurodegeneration but rather neuronal communication deficits.

Purpose of the Study:

• To summarize current findings on Rett syndrome (RTT) from patient and mouse models.
• To investigate the role of mitochondrial dysfunction in RTT pathogenesis.
• To identify open questions for understanding and targeting RTT's cellular redox imbalance.

Main Methods:

• Review of patient data and findings from transgenic mouse models of Rett syndrome (RTT).
• Analysis of evidence linking mitochondrial alterations and redox imbalance to RTT.
• Identification of therapeutic strategies targeting mitochondrial function and oxidative stress.

Main Results:

• Findings from patients and mouse models strongly suggest Rett syndrome (RTT) is a mitochondrial disease.
• Mitochondrial alterations and aberrant redox homeostasis are key features of RTT.
• Pharmacotherapies, antioxidants, and mitochondrial enhancers show potential for RTT treatment.

Conclusions:

• Rett syndrome (RTT) is fundamentally a mitochondrial disorder.
• Understanding the cellular redox imbalance is crucial for developing effective RTT therapies.
• Further research is needed to clarify open questions regarding RTT's molecular mechanisms and treatment targets.